InvestorsHub Logo
icon url

trustedprotege

03/11/13 3:45 PM

#66551 RE: JG36 #66549

I should've paid more attention in my microbiology classes :P I like the way you explained it better than my teacher did back in the day, concise!
icon url

BonelessCat

03/11/13 3:49 PM

#66552 RE: JG36 #66549

So, one could develop ligands that exploit the biological function of a bacteria and the points of cell entry to deliver either a knockout punch of an antibacterial payload, the original concept for the Therapeutic Courier that became a Nanoviricide. Or, use those key metabolic points to punch holes in the bacterial cell membrane, this disgorging the contents and killing otherwise resistant bacteria.

Still, you're right. The company is "Nanoviricides, Inc," and not "Nanoviricides and Nanobacteriacides, Inc."
icon url

Ubertino

03/11/13 5:21 PM

#66555 RE: JG36 #66549

Correct. But you missed the action on bacteria that is in those refs I cited - they work by disrupting the bacterial outer membrane and thus destroy the bacteria - the exact same way that viricides work - by destroying the surrounding viral membrane.